ISWM
AIM

Intesa Sanpaolo Wealth Management’s AIM ImmunoTech AIM Stock Holding History

Intesa Sanpaolo Wealth Management’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
1
– – ﹤0.01% 336
2026
Q1 		$1 Hold
1
– – ﹤0.01% 293
2025
Q4 		$1 Buy
+1
New +$2 ﹤0.01% 286

Other funds holding AIM

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Intesa Sanpaolo Wealth Management's AIM Position: Q2 2026 in Review

Intesa Sanpaolo Wealth Management held its AIM ImmunoTech (AIM) position steady in Q2 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #336.

Intesa Sanpaolo Wealth Management first reported a position in AIM in Q4 2025 and has held it in 3 quarters since. The position peaked at $1 in Q1 2026. 18 funds tracked by Wall St. Rank hold AIM as of Q2 2026.

  • Intesa Sanpaolo Wealth Management held 1 share of AIM ImmunoTech worth $0 as of Q2 2026.
  • Intesa Sanpaolo Wealth Management left its AIM ImmunoTech share count unchanged in Q2 2026.
  • AIM ImmunoTech made up ﹤0.01% of Intesa Sanpaolo Wealth Management's portfolio in Q2 2026, its #336 holding.
  • Intesa Sanpaolo Wealth Management first reported a position in AIM ImmunoTech in Q4 2025 and has held it in 3 quarters since.
  • Intesa Sanpaolo Wealth Management's AIM ImmunoTech position peaked at $1 in Q1 2026.
  • 18 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2026.

Based on Intesa Sanpaolo Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.